US Military Drill in Venezuela Signals Geopolitical Risk Amid Political Transition Fed Chair Powell Vows Not to Be a Shadow Chair as Potential Clash with Warsh Looms Wall Street Edges Higher as Investors Monitor Iran Peace Talks Estee Lauder and Zoom Surge SK Hynix Achieves Record Profit in Fourth Quarter Fueled by AIDriven Chip Demand Coastal Erosion Threatens UK Property Values and Infrastructure Spending The Slapton Line Case Microsofts GitHub Faces AI Coding Race Challenges Amid Outages and Competition COFS Q1 2026 Earnings Earnings Beat Estimates as EPS Surpasses Consensus ATNM Q1 2026 Earnings NarrowerthanExpected Loss Highlights Controlled Spending Amid Clinical Progress SPS Commerce Q1 2026 Earnings EPS Surprises to the Upside as Operating Discipline Supports Bottom Line NAGE Q1 2026 Earnings Modest EPS Beat Amid Limited Revenue Disclosure Marriott International Q1 2026 Earnings EPS Beats Estimates by 546 Shares Edge Lower Insulet PODD Holds Steady Near Support as Trading Volume Remains Subdued IHS Holding Stock Sees Minor Decline Amid Cautious Trading Key Levels in Focus Hall Chadwick Acquisition Corp Unit HCACU Inches Higher as Support Holds Invesco High Income Trust II VLT Holds Steady Near Resistance Level Aberdeen India Fund IFN Holds Steady Amid Market Uncertainty Geopolitical Tensions Rise Fresh US Strikes Complicate Iran Nuclear Deal Negotiations NTB Q1 2026 Earnings EPS Surges Past Estimates by 82 CP Shares Edge Lower Amid Sector Headwinds VTVT Q1 2026 Earnings Massive EPS Beat Driven by OneTime Items Stock Declines LFCR Q1 2026 Earnings Wider Loss Than Expected Despite Positive Stock Reaction Inuvo Q1 2026 Earnings Deep Profit Beat Drives Strong Stock Reaction Forte Biosciences Q1 2026 Earnings Prerevenue Biotech Misses EPS Estimates Stock Dips on Narrower Loss Miss Select Water Solutions WTTR Q1 2026 Earnings Strong EPS Beat Masks Mixed Sentiment Shares Dip Despite Profit Surprise CTSO Q1 2026 Earnings Loss Widens as EPS Misses Estimates Stock Gains 642 Nkarta Inc NKTX Q1 2026 Earnings Narrower Loss Surprises as PreRevenue Biotech Advances Pipeline